Survivorship Care For Long-Term Responder Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC): Feasibility of a Multi-Disciplinary Team (MDT) Consultatio

Not Applicable

Recruiting

• Conditions: metastatic non-small cell lung cancer; metastatic cancer survivorship; Cancer - Lung - Non small cell

• Registration Number: ACTRN12622001165774
• Lead Sponsor: Chris O'Brien Lifehouse

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-08-24
• Last Update Posted: 27 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Histologically confirmed unresectable locally advanced or metastatic NSCLC
2. Age >/= 18 years
3. Able to understand, speak and read in English without the use of an interpreter
4. >/= 6 months post initiation of current line of systemic therapy without radiological evidence of disease progression (stable disease, complete or partial response on CT performed within 3 months prior to enrolment; or complete or partial metabolic response, or stable disease on PET)
5. Able to give informed written consent
6. Access to computer with internet connection

Exclusion Criteria

1. Psychiatric comorbidity that would preclude participation in the study procedures
2. A diagnosis of unresectable NSCLC that is being managed with ‘definitive’ or ‘curative’ intent (eg patients with stage III NSCLC undergoing concurrent chemoradiotherapy followed by consolidation durvalumab)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility: % of patient participants successfully completing the MDT consultation following written consent<br><br>Data collected via audit of study records.[6 weeks post recruitment of last (30th) participant to study OR 2 years post recruitment of first participant to study whichever is sooner.]